Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2311243 Target Snapshot

D-3-phosphoglycerate dehydrogenase · SINGLE PROTEIN · Homo sapiens

781Compounds
118Assays
1Approved Drugs
1,320.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt O43175. Use UniProt O43175 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O43175 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats D-3-phosphoglycerate dehydrogenase as ChEMBL target CHEMBL2311243, mapped to UniProt O43175. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
D-3-phosphoglycerate dehydrogenase
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2311243
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
O43175
D-3-phosphoglycerate dehydrogenase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether D-3-phosphoglycerate dehydrogenase is the right protein anchor across sources, using UniProt O43175 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelD-3-phosphoglycerate dehydrogenase
UniProt AccessionO43175
Component TypeProtein
Sequence Length533 aa

D-3-phosphoglycerate dehydrogenase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as D-3-phosphoglycerate dehydrogenase, mapped to UniProt O43175. Sequence length is 533 aa.

Mapped IDO43175
Review nameD-3-phosphoglycerate dehydrogenase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC501,280.0
KI5.0
EC502.0
KD33.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4541133 9.52 IC50 0.3 Preclinical
CHEMBL4536737 9.1 IC50 0.8 Preclinical
CHEMBL4584313 8.8 IC50 1.6 Preclinical
CHEMBL4436264 8.7 IC50 2.0 Preclinical
CHEMBL4518579 8.54 IC50 2.9 Preclinical
CHEMBL4467246 8.52 IC50 3.0 Preclinical
CHEMBL4515492 8.52 IC50 3.0 Preclinical
CHEMBL4520837 8.52 IC50 3.0 Preclinical
CHEMBL4527607 8.52 IC50 3.0 Preclinical
CHEMBL4579388 8.48 IC50 3.3 Preclinical
Distribution

pChEMBL Value Distribution

192
5.0
107
5.5
101
6.0
142
6.5
75
7.0
63
7.5
68
8.0
11
8.5
1
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

DISULFIRAM
CHEMBL964
Approved 1951
Assay Landscape

Assay Landscape

118
Total Assays
881
Tested Compounds
1
Assay Types
Binding — 118 assays, 881 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 62 486 5.9
assay format 29 302 6.1
cell-based format 25 83 6.3
organism-based format 1 10 4.5
subcellular format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine